COVID-19 Impact on Global Biliary Tumor Market Size, Status and Forecast 2020-2026
- BMR3871641
- 96 Pages
- June 2020
- Healthcare
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biliary Tumor market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Biliary Tumor industry.
Based on our recent survey, we have several different scenarios about the Biliary Tumor YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biliary Tumor will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biliary Tumor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biliary Tumor market in terms of revenue.
Players, stakeholders, and other participants in the global Biliary Tumor market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Biliary Tumor market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Biliary Tumor market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biliary Tumor market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biliary Tumor market.
The following players are covered in this report:
NuCana
NeoGenomics
Novartis
GlaxoSmithKline
Southwest Oncology Group
...
Biliary Tumor Breakdown Data by Type
Mecine
Surgery
Other
Biliary Tumor Breakdown Data by Application
Hospitals
Clinics
Other
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biliary Tumor Revenue
1.4 Market Analysis by Type
1.4.1 Global Biliary Tumor Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Mecine
1.4.3 Surgery
1.4.4 Other
1.5 Market by Application
1.5.1 Global Biliary Tumor Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Biliary Tumor Industry Impact
1.6.1 How the Covid-19 is Affecting the Biliary Tumor Industry
1.6.1.1 Biliary Tumor Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biliary Tumor Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biliary Tumor Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Biliary Tumor Market Perspective (2015-2026)
2.2 Biliary Tumor Growth Trends by Regions
2.2.1 Biliary Tumor Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biliary Tumor Historic Market Share by Regions (2015-2020)
2.2.3 Biliary Tumor Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biliary Tumor Market Growth Strategy
2.3.6 Primary Interviews with Key Biliary Tumor Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Biliary Tumor Players by Market Size
3.1.1 Global Top Biliary Tumor Players by Revenue (2015-2020)
3.1.2 Global Biliary Tumor Revenue Market Share by Players (2015-2020)
3.1.3 Global Biliary Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biliary Tumor Market Concentration Ratio
3.2.1 Global Biliary Tumor Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biliary Tumor Revenue in 2019
3.3 Biliary Tumor Key Players Head office and Area Served
3.4 Key Players Biliary Tumor Product Solution and Service
3.5 Date of Enter into Biliary Tumor Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Biliary Tumor Historic Market Size by Type (2015-2020)
4.2 Global Biliary Tumor Forecasted Market Size by Type (2021-2026)
5 Biliary Tumor Breakdown Data by Application (2015-2026)
5.1 Global Biliary Tumor Market Size by Application (2015-2020)
5.2 Global Biliary Tumor Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Biliary Tumor Market Size (2015-2020)
6.2 Biliary Tumor Key Players in North America (2019-2020)
6.3 North America Biliary Tumor Market Size by Type (2015-2020)
6.4 North America Biliary Tumor Market Size by Application (2015-2020)
7 Europe
7.1 Europe Biliary Tumor Market Size (2015-2020)
7.2 Biliary Tumor Key Players in Europe (2019-2020)
7.3 Europe Biliary Tumor Market Size by Type (2015-2020)
7.4 Europe Biliary Tumor Market Size by Application (2015-2020)
8 China
8.1 China Biliary Tumor Market Size (2015-2020)
8.2 Biliary Tumor Key Players in China (2019-2020)
8.3 China Biliary Tumor Market Size by Type (2015-2020)
8.4 China Biliary Tumor Market Size by Application (2015-2020)
9 Japan
9.1 Japan Biliary Tumor Market Size (2015-2020)
9.2 Biliary Tumor Key Players in Japan (2019-2020)
9.3 Japan Biliary Tumor Market Size by Type (2015-2020)
9.4 Japan Biliary Tumor Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Biliary Tumor Market Size (2015-2020)
10.2 Biliary Tumor Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biliary Tumor Market Size by Type (2015-2020)
10.4 Southeast Asia Biliary Tumor Market Size by Application (2015-2020)
11 India
11.1 India Biliary Tumor Market Size (2015-2020)
11.2 Biliary Tumor Key Players in India (2019-2020)
11.3 India Biliary Tumor Market Size by Type (2015-2020)
11.4 India Biliary Tumor Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Biliary Tumor Market Size (2015-2020)
12.2 Biliary Tumor Key Players in Central & South America (2019-2020)
12.3 Central & South America Biliary Tumor Market Size by Type (2015-2020)
12.4 Central & South America Biliary Tumor Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 NuCana
13.1.1 NuCana Company Details
13.1.2 NuCana Business Overview and Its Total Revenue
13.1.3 NuCana Biliary Tumor Introduction
13.1.4 NuCana Revenue in Biliary Tumor Business (2015-2020))
13.1.5 NuCana Recent Development
13.2 NeoGenomics
13.2.1 NeoGenomics Company Details
13.2.2 NeoGenomics Business Overview and Its Total Revenue
13.2.3 NeoGenomics Biliary Tumor Introduction
13.2.4 NeoGenomics Revenue in Biliary Tumor Business (2015-2020)
13.2.5 NeoGenomics Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview and Its Total Revenue
13.3.3 Novartis Biliary Tumor Introduction
13.3.4 Novartis Revenue in Biliary Tumor Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.4.3 GlaxoSmithKline Biliary Tumor Introduction
13.4.4 GlaxoSmithKline Revenue in Biliary Tumor Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Southwest Oncology Group
13.5.1 Southwest Oncology Group Company Details
13.5.2 Southwest Oncology Group Business Overview and Its Total Revenue
13.5.3 Southwest Oncology Group Biliary Tumor Introduction
13.5.4 Southwest Oncology Group Revenue in Biliary Tumor Business (2015-2020)
13.5.5 Southwest Oncology Group Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Biliary Tumor Key Market Segments
Table 2. Key Players Covered: Ranking by Biliary Tumor Revenue
Table 3. Ranking of Global Top Biliary Tumor Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biliary Tumor Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Mecine
Table 6. Key Players of Surgery
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Biliary Tumor Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Biliary Tumor Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Biliary Tumor Players to Combat Covid-19 Impact
Table 13. Global Biliary Tumor Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Biliary Tumor Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Biliary Tumor Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Biliary Tumor Market Share by Regions (2015-2020)
Table 17. Global Biliary Tumor Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Biliary Tumor Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Biliary Tumor Market Growth Strategy
Table 23. Main Points Interviewed from Key Biliary Tumor Players
Table 24. Global Biliary Tumor Revenue by Players (2015-2020) (Million US$)
Table 25. Global Biliary Tumor Market Share by Players (2015-2020)
Table 26. Global Top Biliary Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Tumor as of 2019)
Table 27. Global Biliary Tumor by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Biliary Tumor Product Solution and Service
Table 30. Date of Enter into Biliary Tumor Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Biliary Tumor Market Size by Type (2015-2020) (Million US$)
Table 33. Global Biliary Tumor Market Size Share by Type (2015-2020)
Table 34. Global Biliary Tumor Revenue Market Share by Type (2021-2026)
Table 35. Global Biliary Tumor Market Size Share by Application (2015-2020)
Table 36. Global Biliary Tumor Market Size by Application (2015-2020) (Million US$)
Table 37. Global Biliary Tumor Market Size Share by Application (2021-2026)
Table 38. North America Key Players Biliary Tumor Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Biliary Tumor Market Share (2019-2020)
Table 40. North America Biliary Tumor Market Size by Type (2015-2020) (Million US$)
Table 41. North America Biliary Tumor Market Share by Type (2015-2020)
Table 42. North America Biliary Tumor Market Size by Application (2015-2020) (Million US$)
Table 43. North America Biliary Tumor Market Share by Application (2015-2020)
Table 44. Europe Key Players Biliary Tumor Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Biliary Tumor Market Share (2019-2020)
Table 46. Europe Biliary Tumor Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Biliary Tumor Market Share by Type (2015-2020)
Table 48. Europe Biliary Tumor Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Biliary Tumor Market Share by Application (2015-2020)
Table 50. China Key Players Biliary Tumor Revenue (2019-2020) (Million US$)
Table 51. China Key Players Biliary Tumor Market Share (2019-2020)
Table 52. China Biliary Tumor Market Size by Type (2015-2020) (Million US$)
Table 53. China Biliary Tumor Market Share by Type (2015-2020)
Table 54. China Biliary Tumor Market Size by Application (2015-2020) (Million US$)
Table 55. China Biliary Tumor Market Share by Application (2015-2020)
Table 56. Japan Key Players Biliary Tumor Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Biliary Tumor Market Share (2019-2020)
Table 58. Japan Biliary Tumor Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Biliary Tumor Market Share by Type (2015-2020)
Table 60. Japan Biliary Tumor Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Biliary Tumor Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Biliary Tumor Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Biliary Tumor Market Share (2019-2020)
Table 64. Southeast Asia Biliary Tumor Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Biliary Tumor Market Share by Type (2015-2020)
Table 66. Southeast Asia Biliary Tumor Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Biliary Tumor Market Share by Application (2015-2020)
Table 68. India Key Players Biliary Tumor Revenue (2019-2020) (Million US$)
Table 69. India Key Players Biliary Tumor Market Share (2019-2020)
Table 70. India Biliary Tumor Market Size by Type (2015-2020) (Million US$)
Table 71. India Biliary Tumor Market Share by Type (2015-2020)
Table 72. India Biliary Tumor Market Size by Application (2015-2020) (Million US$)
Table 73. India Biliary Tumor Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Biliary Tumor Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Biliary Tumor Market Share (2019-2020)
Table 76. Central & South America Biliary Tumor Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Biliary Tumor Market Share by Type (2015-2020)
Table 78. Central & South America Biliary Tumor Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Biliary Tumor Market Share by Application (2015-2020)
Table 80. NuCana Company Details
Table 81. NuCana Business Overview
Table 82. NuCana Product
Table 83. NuCana Revenue in Biliary Tumor Business (2015-2020) (Million US$)
Table 84. NuCana Recent Development
Table 85. NeoGenomics Company Details
Table 86. NeoGenomics Business Overview
Table 87. NeoGenomics Product
Table 88. NeoGenomics Revenue in Biliary Tumor Business (2015-2020) (Million US$)
Table 89. NeoGenomics Recent Development
Table 90. Novartis Company Details
Table 91. Novartis Business Overview
Table 92. Novartis Product
Table 93. Novartis Revenue in Biliary Tumor Business (2015-2020) (Million US$)
Table 94. Novartis Recent Development
Table 95. GlaxoSmithKline Company Details
Table 96. GlaxoSmithKline Business Overview
Table 97. GlaxoSmithKline Product
Table 98. GlaxoSmithKline Revenue in Biliary Tumor Business (2015-2020) (Million US$)
Table 99. GlaxoSmithKline Recent Development
Table 100. Southwest Oncology Group Company Details
Table 101. Southwest Oncology Group Business Overview
Table 102. Southwest Oncology Group Product
Table 103. Southwest Oncology Group Revenue in Biliary Tumor Business (2015-2020) (Million US$)
Table 104. Southwest Oncology Group Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biliary Tumor Market Share by Type: 2020 VS 2026
Figure 2. Mecine Features
Figure 3. Surgery Features
Figure 4. Other Features
Figure 5. Global Biliary Tumor Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Biliary Tumor Report Years Considered
Figure 10. Global Biliary Tumor Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Biliary Tumor Market Share by Regions: 2020 VS 2026
Figure 12. Global Biliary Tumor Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Biliary Tumor Market Share by Players in 2019
Figure 15. Global Top Biliary Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Tumor as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Biliary Tumor Revenue in 2019
Figure 17. North America Biliary Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Biliary Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Biliary Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Biliary Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Biliary Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Biliary Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Biliary Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. NuCana Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. NuCana Revenue Growth Rate in Biliary Tumor Business (2015-2020)
Figure 26. NeoGenomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. NeoGenomics Revenue Growth Rate in Biliary Tumor Business (2015-2020)
Figure 28. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Novartis Revenue Growth Rate in Biliary Tumor Business (2015-2020)
Figure 30. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. GlaxoSmithKline Revenue Growth Rate in Biliary Tumor Business (2015-2020)
Figure 32. Southwest Oncology Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Southwest Oncology Group Revenue Growth Rate in Biliary Tumor Business (2015-2020)
Figure 34. Bottom-up and Top-down Approaches for This Report
Figure 35. Data Triangulation
Figure 36. Key Executives Interviewed
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
